Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Liver Cancer
100%
Peroxisome Proliferator-activated Receptor
96%
Hepatocarcinogenesis
24%
Inflammatory Pathways
24%
Tumor Promotion
19%
Transcription Factor
16%
Kupffer Cells
16%
Epigenetic Modulation
16%
Liver Toxicity
16%
Etiology
11%
Signaling Molecules
8%
Surgical Treatment
8%
Tumor Formation
8%
Conditional Deletion
8%
Mutant Forms
8%
High Affinity
8%
Cellular Homeostasis
8%
Treatment Strategy
8%
Cell Adhesion Molecules
8%
Transgenic Mice
8%
Epigenetics
8%
Cancer Types
8%
Chemotherapy Treatment
8%
Innovative Study
8%
DNA-binding Domain
8%
GW0742
8%
United States
8%
Null Mice
8%
Molecular Pathways
8%
Molecular Targets
8%
Chronic Inflammatory Diseases
8%
Ppar
8%
Human Mortality
8%
Inpatient Treatment
8%
Sigma-1 Receptor
8%
Primary Liver Cancer
8%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cancer
100%
Peroxisome Proliferator Activated Receptor
96%
Liver Carcinogenesis
24%
Tumor Promotion
19%
Hepatotoxicity
16%
Transcription Factors
16%
Etiology
11%
Carcinogenesis
8%
Cytokine
8%
Cell Adhesion Proteins
8%
Anti-Inflammatory Drug
8%
Diseases
8%
Transgenic Mouse
8%
Transgenic Organism
8%
Molecular Target
8%
Inflammatory Disease
8%
Chemokine
8%
[4 [2 (3 Fluoro 4 Trifluoromethylphenyl) 4 Methyl 5 Thiazolylmethylthio] 2 Methylphenoxy]acetic Acid
8%
Liver Tumor
8%
Malignant Neoplasm
8%
Knockout Mouse
8%
Chemotherapy Regimens
8%